Ernexa Therapeutics Inc.

US$1.88As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ERNAHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (81.97%)
Div yield —
ROE (352.43%)
Biotechnology
Beta (5Y) 2.74
PE TTM —
TSR TTM (96.00%)
Mkt cap US$3.069M
ROIC (182.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.35
25.08%
(36.03%)
Hold 6|9|3|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.03
0.03
21.77%
19.28%
24.57%
17.43%
Revenue$M
0.174
0.177
0.177
0.179
5.58%
6.26%
1.41%
0.88%
Peers (US$3.069M)
Cap (US$)
PE
3.015M
—
2.990M
—
Capital
TTM
5Y
10Y
Leveragex
0.410
0.128
0.107
EBIT/Intx
0.643
0.455
0.455
Own earn%
(187.85)
39.17
7.67
Sh yield%
32.27
40.30
42.24
Owners
Insiders/Inst%
9.55
23.15
Short interest%
5.92
SBC / revenue%
3.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
24–28
$1 testx
0.2
Incr. ROIC%
12